Hyperlipidemia in a myeloma patient after bortezomib treatment.
Gozzetti
Alessandro
A
Fabbri
Alberto
A
Defina
Marzia
M
Chitarrelli
Ida
I
Bocchia
Monica
M
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001897:Boronic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D000069286:Bortezomib; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D009101:Multiple Myeloma / Q000188:drug therapy*; D011719:Pyrazines / Q000009:adverse effects* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib